🇺🇸 Lexicon Pharmaceuticals, Inc.
Forum topic · LXRX · Company page: financials, ownership and filings
Join the discussion on Lexicon Pharmaceuticals, Inc.
Loading…
Results announced on 5 November 2026
Lexicon Pharmaceuticals, Inc. announced results on 5 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $11 million (down 21% from a year earlier) and a net loss of $14 million.
Mutual funds: 71 funds hold $130 million
71 mutual funds in 1 country hold shares of Lexicon Pharmaceuticals, Inc. worth $130 million, about 12.8% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 63 funds added shares and 4 sold; on balance they bought $49 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.